Patents by Inventor Nancy Scott

Nancy Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable formulations for parenteral injection of small molecule drugs
    Patent number: 11446310
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: September 20, 2022
    Assignee: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. Prestrelski, Nancy Scott
  • STABLE FORMULATIONS FOR PARENTERAL INJECTION OF SMALL MOLECULE DRUGS
    Publication number: 20200368250
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Application
    Filed: July 31, 2020
    Publication date: November 26, 2020
    Applicant: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. PRESTRELSKI, Nancy SCOTT
  • Stable formulations for parenteral injection of small molecule drugs
    Patent number: 10765683
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: September 8, 2020
    Assignee: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. Prestrelski, Nancy Scott
  • STABLE FORMULATIONS FOR PARENTERAL INJECTION OF SMALL MOLECULE DRUGS
    Publication number: 20160151385
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Application
    Filed: July 29, 2015
    Publication date: June 2, 2016
    Inventors: Steven J. PRESTRELSKI, Nancy SCOTT
  • Stable formulations for parenteral injection of small molecule drugs
    Patent number: 9125805
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 8, 2015
    Assignee: Xeris Pharmaceuticals, Inc.
    Inventors: Steven J. Prestrelski, Nancy Scott
  • FORMULATIONS FOR THE TREATMENT OF DIABETES
    Publication number: 20140349926
    Abstract: Disclosed is a formulation for parenteral administration comprising insulin that comprises a pH memory between 1 to 4 or between 6 to 8 and an aprotic polar solvent, wherein the insulin is solubilized in the aprotic polar solvent, wherein the solubilized insulin comprises stable monomeric or dimeric forms of insulin or mixtures thereof, and wherein the water content of the formulation is equal to or less than 15% w/v.
    Type: Application
    Filed: October 31, 2012
    Publication date: November 27, 2014
    Inventors: Steven Prestrelski, Nancy Scott
  • STABLE FORMULATIONS FOR PARENTERAL INJECTION OF SMALL MOLECULE DRUGS
    Publication number: 20140005135
    Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.
    Type: Application
    Filed: March 14, 2013
    Publication date: January 2, 2014
    Applicant: XERIS PHARMACEUTICALS, INC.
    Inventors: Steven J. Prestrelski, Nancy Scott